Skip to main content
Year archive

Genomictree Inc. — 2020 filings

All 31 regulatory filings released by Genomictree Inc. (228760) in 2020, sourced directly from the official regulator.

31 Filings
2020 Period
2020 filings (31)
Filing Released Lang
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2020-12-17 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2020-12-10 Korean
투자판단관련주요경영사항(폐암 조기진단 보조용 체외분자진단제품 (EarlyTect Lung Cancer) 의료기기 제조허가 반려)
Legal Proceedings Report
2020-12-07 Korean
기업설명회(IR)개최
Report Publication Announcement
2020-12-02 Korean
분기보고서 (2020.09)
Interim / Quarterly Report 9M 2020
2020-11-13 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2020-11-03 Korean
[기재정정]주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2020-10-29 Korean
투자판단관련주요경영사항(대장암 조기진단 기술 이전 관련 구속력 있는 양해각서(Binding MOU) 체결의 건)
M&A Activity
2020-10-29 Korean
단일판매ㆍ공급계약체결
Regulatory Filings
2020-09-08 Korean
반기보고서 (2020.06)
Interim / Quarterly Report H1 2020
2020-08-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-08-06 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2020-08-06 Korean
분기보고서 (2020.03)
Interim / Quarterly Report Q1 2020
2020-05-14 Korean
단일판매ㆍ공급계약체결
Capital/Financing Update
2020-05-13 Korean
단일판매ㆍ공급계약체결
Regulatory Filings
2020-04-24 Korean
사업보고서 (2019.12)
Annual Report FY 2019
2020-03-27 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2020-03-24 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2020-03-24 Korean
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-03-19 Korean
감사보고서제출
Audit Report / Information FY 2019
2020-03-16 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2020-03-13 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2020-03-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2020-03-13 Korean
주주총회소집공고
AGM Information
2020-03-09 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2020-03-06 Korean
투자판단관련주요경영사항(폐암 조기진단 보조용 체외분자진단제품 (EarlyTect Lung Cancer) 판매를 위한 의료기기 제조허가 신청)
Regulatory Filings
2020-03-02 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2019
2020-02-24 Korean
기타주요경영사항(종속회사의주요경영사항)
Capital/Financing Update
2020-01-20 Korean
유상증자결정(종속회사의주요경영사항)
Share Issue/Capital Change
2020-01-09 Korean
[첨부추가]타법인주식및출자증권취득결정
Capital/Financing Update
2020-01-09 Korean
투자판단관련주요경영사항(폐암 진단용 종양관련유전자검사시약(GT-LC-1)의 확증임상시험 결과 공지)
Regulatory Filings
2020-01-02 Korean